MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kearney, P. C.
Right arrow Articles by Dougherty, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kearney, P. C.
Right arrow Articles by Dougherty, D. A.

Dose-response relations for unnatural amino acids at the agonist binding site of the nicotinic acetylcholine receptor: tests with novel side chains and with several agonists

PC Kearney, MW Nowak, W Zhong, SK Silverman, HA Lester and DA Dougherty

Division of Biology, California Institute of Technology, Pasadena 91125, USA.

Structure-function relations in the nicotinic acetylcholine receptor are probed using a recently developed method based on chemical synthesis of nonsense suppressor tRNAs with unnatural amino acid residues, site-directed incorporation at nonsense codons in Xenopus laevis oocytes, and electrophysiological measurements. A broad range of unnatural amino acids, as many as 14 at a given site, are incorporated at three sites, alpha 93, alpha 190, and alpha 198, all of which are tyrosine in the wild-type receptor and are thought to contribute to the agonist binding site. Confirming and expanding upon earlier studies using conventional mutagenesis, the three tyrosines are shown to be in substantially different structural microenvironments. In particular, a crucial role is established for the hydroxyl group of alpha Tyr93, whereas a variety of substituents are functional at the analogous position of alpha Tyr198. Interestingly, consideration of three different agonists (acetylcholine, nicotine, and tetramethylammonium) does not discriminate between these two best-characterized binding site residues. In addition, double-mutation studies establish the independent effects of mutations at the pore region (second transmembrane region) and at the agonist binding site, and this observation leads to a novel strategy for adjusting EC50 values. These results establish the broad generality and great potential of the unnatural amino acid methodology for illuminating subtle structural distinctions in neuroreceptors and related integral membrane proteins.

Volume 50, Issue 5, pp. 1401-1412, 11/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. L. Padgett, A. P. Hanek, H. A. Lester, D. A. Dougherty, and S. C. R. Lummis
Unnatural Amino Acid Mutagenesis of the GABAA Receptor Binding Site Residues Reveals a Novel Cation-{pi} Interaction between GABA and {beta}2Tyr97
J. Neurosci., January 24, 2007; 27(4): 886 - 892.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. A. Rodriguez, H. A. Lester, and D. A. Dougherty
In vivo incorporation of multiple unnatural amino acids through nonsense and frameshift suppression
PNAS, June 6, 2006; 103(23): 8650 - 8655.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Xiu, A. P. Hanek, J. Wang, H. A. Lester, and D. A. Dougherty
A Unified View of the Role of Electrostatic Interactions in Modulating the Gating of Cys Loop Receptors
J. Biol. Chem., December 16, 2005; 280(50): 41655 - 41666.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. L. Beene, K. L. Price, H. A. Lester, D. A. Dougherty, and S. C. R. Lummis
Tyrosine Residues That Control Binding and Gating in the 5-Hydroxytryptamine3 Receptor Revealed by Unnatural Amino Acid Mutagenesis
J. Neurosci., October 13, 2004; 24(41): 9097 - 9104.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. L. Price and S. C. R. Lummis
The Role of Tyrosine Residues in the Extracellular Domain of the 5-Hydroxytryptamine3 Receptor
J. Biol. Chem., May 28, 2004; 279(22): 23294 - 23301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Ryan, D. G. Hill, and J. E. Baenziger
Dissecting the Chemistry of Nicotinic Receptor-Ligand Interactions with Infrared Difference Spectroscopy
J. Biol. Chem., March 15, 2002; 277(12): 10420 - 10426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. D. Philipson, J. P. Gallivan, G. S. Brandt, D. A. Dougherty, and H. A. Lester
Incorporation of caged cysteine and caged tyrosine into a transmembrane segment of the nicotinic ACh receptor
Am J Physiol Cell Physiol, July 1, 2001; 281(1): C195 - C206.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Zhong, J. P. Gallivan, Y. Zhang, L. Li, H. A. Lester, and D. A. Dougherty
From ab initio quantum mechanics to molecular neurobiology: A cation-pi binding site in the nicotinic receptor
PNAS, October 13, 1998; 95(21): 12088 - 12093.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P.-J. Corringer, S. Bertrand, S. Bohler, S. J. Edelstein, J.-P. Changeux, and D. Bertrand
Critical Elements Determining Diversity in Agonist Binding and Desensitization of Neuronal Nicotinic Acetylcholine Receptors
J. Neurosci., January 15, 1998; 18(2): 648 - 657.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. M. England, H. A. Lester, N. Davidson, and D. A. Dougherty
Site-specific, photochemical proteolysis applied to ion channels in vivo
PNAS, September 30, 1997; 94(20): 11025 - 11030.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics